YAEL MARGOLIN - 01 Jun 2023 Form 4 Insider Report for POINT Biopharma Global Inc. (PNT)

Role
Director
Signature
/s/ William L. Demers, by Power of Attorney for Yael Margolin
Issuer symbol
PNT
Transactions as of
01 Jun 2023
Transactions value $
$0
Form type
4
Filing time
05 Jun 2023, 17:35:59 UTC
Previous filing
23 Jan 2023
Next filing
27 Dec 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PNT Stock Option (Right to Buy) Award $0 +44,749 $0.000000 44,749 01 Jun 2023 Common Stock 44,749 $9.12 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option will vest 100% on the first anniversary of the grant date.